Glenview Trust’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q3 | – | Sell |
-1,679
| Closed | -$342K | – | 406 |
|
2022
Q2 | $342K | Sell |
1,679
-391
| -19% | -$79.6K | 0.01% | 337 |
|
2022
Q1 | $436K | Sell |
2,070
-200
| -9% | -$42.1K | 0.01% | 320 |
|
2021
Q4 | $545K | Sell |
2,270
-3,121
| -58% | -$749K | 0.02% | 278 |
|
2021
Q3 | $1.53M | Sell |
5,391
-40
| -0.7% | -$11.3K | 0.06% | 167 |
|
2021
Q2 | $1.88M | Sell |
5,431
-877
| -14% | -$304K | 0.07% | 152 |
|
2021
Q1 | $1.76M | Buy |
6,308
+603
| +11% | +$169K | 0.08% | 148 |
|
2020
Q4 | $1.4M | Buy |
5,705
+2,228
| +64% | +$546K | 0.06% | 160 |
|
2020
Q3 | $986K | Sell |
3,477
-10
| -0.3% | -$2.84K | 0.05% | 177 |
|
2020
Q2 | $933K | Buy |
3,487
+53
| +2% | +$14.2K | 0.05% | 176 |
|
2020
Q1 | $1.09M | Buy |
3,434
+49
| +1% | +$15.5K | 0.08% | 161 |
|
2019
Q4 | $1M | Sell |
3,385
-814
| -19% | -$241K | 0.06% | 177 |
|
2019
Q3 | $977K | Buy |
4,199
+69
| +2% | +$16.1K | 0.06% | 179 |
|
2019
Q2 | $966K | Sell |
4,130
-4,037
| -49% | -$944K | 0.06% | 184 |
|
2019
Q1 | $1.93M | Sell |
8,167
-6,222
| -43% | -$1.47M | 0.12% | 141 |
|
2018
Q4 | $4.33M | Sell |
14,389
-17,423
| -55% | -$5.24M | 0.32% | 92 |
|
2018
Q3 | $11.2M | Buy |
31,812
+16
| +0.1% | +$5.65K | 0.71% | 42 |
|
2018
Q2 | $9.23M | Buy |
31,796
+446
| +1% | +$129K | 0.69% | 40 |
|
2018
Q1 | $8.58M | Sell |
31,350
-41
| -0.1% | -$11.2K | 0.59% | 52 |
|
2017
Q4 | $10M | Buy |
31,391
+199
| +0.6% | +$63.4K | 0.69% | 45 |
|
2017
Q3 | $9.77M | Sell |
31,192
-1,211
| -4% | -$379K | 0.72% | 46 |
|
2017
Q2 | $8.79M | Buy |
32,403
+85
| +0.3% | +$23.1K | 0.68% | 52 |
|
2017
Q1 | $8.84M | Buy |
32,318
+2,110
| +7% | +$577K | 0.7% | 47 |
|
2016
Q4 | $8.57M | Buy |
+30,208
| New | +$8.57M | 0.71% | 49 |
|
2015
Q4 | $5.92M | Buy |
+19,309
| New | +$5.92M | 0.61% | 57 |
|
2013
Q4 | $380K | Buy |
+1,359
| New | +$380K | 0.04% | 157 |
|